1. INTRODUCTION
===============

Age-related macular degeneration (AMD), the leading cause of worldwide blindness in the elderly, is a bilateral ocular condition that affects the central area of retina known as the macula. The macula accounts for the majority of photopic (daytime, color) vision in humans. Thus, lesions developing in the macula have a major impact on human vision.

Histopathology features of AMD include focal drusen deposits and a loss of both photoreceptors and retinal pigment epithelial (RPE) cells leading to regional or global retinal atrophy \[[@R1]\].

Clinically, AMD is categorized into the dry (or atrophic) and the wet (or neovascular) forms. The most severe AMD vision loss is associated with patients exhibiting wet AMD while the dry form accounts for 20% of legal blindness in those that suffer from AMD \[[@R2]\].

Studies have suggested that oxidative stress to RPE cells and photoreceptors may contribute to the pathogenesis of age-related macular degeneration \[[@R3]\]. Oxidative stress occurs when reactive oxygen species (ROS) interact with macromolecules which modify their functions. Furthermore, AMD is an age-associated disease which makes aging a risk factor \[[@R4]\]. Although the vision loss of AMD is due to the loss of photoreceptors in the central retina, the initial pathogenesis of the disease involves degeneration of RPE cells \[[@R5]\]. Studies have suggested that RPE cells undergo an accelerated aging process \[[@R6]\] and since the loss of RPE cells is the critical event leading to irreversible vision loss, our aim is to examine oxidative damage to human retinal pigment epithelial cells in a cell line (ARPE19) with senescence-related changes \[[@R7]\]. Our experimental results show that oxidative stress by hydrogen peroxide treatment led to enhanced cell senescence *in vitro*.

2. MATERIALS AND METHODS
========================

2.1. *In Vitro* Model
---------------------

ARPE19 cells were purchased from American Type Culture Collection (ATCC; Manassas, VA, USA). At passage 11, cells were seeded in a T75 flask and cultured until confluent at 37°C with 5% CO~2.~ Cells were grown in Dulbecco\'s Modified Eagle\'s medium and supplemented with 10% Fetal Bovine Serum (FBS) from Life Technologies Co. (Carlsbad, CA, USA).

2.2. Hydrogen Peroxide Treatment
--------------------------------

Cells were trypsinized using Trypsin + EDTA and seeded into 24 well plates at 50,000 cells per well, 1 ml DMEM + 10% FBS. After 24 hours of incubation at 37°C + 5% CO~2~, the growth medium was removed and replaced with serum-free medium (SFM). 24 hours later, the medium of selected wells were changed to SFM + 300 micromolar (or MCM) hydrogen peroxide, SFM + 400 MCM or SFM + 800 MCM. After 90 minutes of hydrogen peroxide treatment, the medium in selected wells were changed to 1 ml of DMEM + 10% FBS for the subsequent study on cell proliferation and senescence.

2.3. Hydrogen Peroxide Treatment on Cell Proliferations
-------------------------------------------------------

To investigate cell proliferation after hydrogen peroxide treatments, cells with and without hydrogen peroxide treatments were incubated for 72 hours and then trypsinized (trypsin + EDTA) and harvested for counting using the Trypan Blue Dye Exclusion Method.

2.4. Hydrogen Peroxide Treatment on Cell Senescence
---------------------------------------------------

To investigate the effect of oxidative stress (induced by hydrogen peroxide) on retinal pigment epithelial cell senescence, ARPE19 cells were stained for S-Beta Galactosidase 24 hours after treatment with hydrogen peroxide. The Senescence Associated Beta-Galactosidase Staining Kit (Category No. K320-250; BioVision Incorporated, Milpitas, CA, USA) was used according to manufacturer's instructions. Stained cells were observed under an inverted microscope for the development of blue color.

3. RESULTS
==========

3.1. Hydrogen Peroxide Treatment Significantly Reduced Cell Proliferation
-------------------------------------------------------------------------

ARPE19 cells with and without hydrogen peroxide treatment were seeded at 50,000 cells per well. After 72 hours of incubation, the number of viable cells in control wells (with 0 MCM hydrogen peroxide treatment) increased to 197,000 cells. On the other hand, the number of viable cells in wells containing hydrogen peroxide treatment exhibited a significantly lower level of cell proliferation. The number of ARPE19 cells with 300 MCM hydrogen peroxide treatment increased from 50,000 to 89,100 viable cells and those treated with 400 and 800 MCM hydrogen peroxide changed from 50,000 to 52,300 and to 48,900 cells respectively. Fig. (**[1](#F1){ref-type="fig"}**) illustrates the changes in viable ARPE19 cell number corresponding to the three hydrogen peroxide treatment concentrations.

3.2. Oxidative Stress (from Hydrogen Peroxide Treatment) Induced ARPE19 Cell Senescence
---------------------------------------------------------------------------------------

Cells without (0 MCM) and with (300 MCM, 400 MCM and 800 MCM) hydrogen peroxide treatments were incubated for 24 hours and stained for Senescence Associated Beta Galactosidase to study the level of cell senescence. Our results show that control (without hydrogen peroxide treatment) exhibited minimal blue stain for Beta Galactosidase (Fig. **[2A](#F2){ref-type="fig"}**) whereas treatment with 300 MCM hydrogen peroxide resulted in an increase in percent of cells exhibiting positive staining (Fig. **[2B](#F2){ref-type="fig"}**). Higher levels of positive staining, in excess of 80%, were noted in cells treated with 400 and 800 MCM hydrogen peroxide (Fig. **[2C](#F2){ref-type="fig"}** and **[D](#F2){ref-type="fig"}**).

3.3. Dose Dependent Increase in Cell Senescence in Response to Oxidative Stress from Hydrogen Peroxide Treatment
----------------------------------------------------------------------------------------------------------------

Based on the percent of ARPE19 cells with positive statining of SA-BETA-GAL, Fig. (**[3](#F3){ref-type="fig"}**) shows an increase in the concentration of hydrogen peroxide in the cell medium led to a corresponding increase in ARPE19 cell senescence. At 0 MCM, a low level of senescence was observed (12% cells with positive staining). This level was increased to 60% with hydrogen peroxide treatment at 300 MCM. At 400 MCM, hydrogen peroxide induced a high level of cell senescence with more than 80% cells stained positive for SA-BETA-GAL; a marker for cell senescence.

4. DISCUSSIONS
==============

Hydrogen peroxide has a profound effect on cell proliferation in the cultured ARPE19 cells. Untreated cells (0 MCM) showed a significant increase in the number of viable cells from 50,000 to 197,000 in a 72 hour incubation period. However, for cells treated with 300 MCM of hydrogen peroxide, the number of viable cells increased only to 89,980 and then to 52,167 when treated with 400 MCM. Cells treated with 800 MCM, exhibited a slight decrease in cell number from 50,000 to 49,263. These results strongly suggest that oxidative stress from hydrogen peroxide treatment posts a significant inhibition of ARPE19 cell proliferation.

This is the first study to show that ARPE cells treated with 0, 300, 400 and 800 MCM hydrogen peroxide significantly increase positive staining for Senescence-Associated Beta Galactosidase [and]{.ul} significantly decrease cell viability. Cells treated with 0 MCM exhibited a background level of senescence (12%) which is consistent with previous reports of senescence related changes in this ARPE19 cell line \[[@R7]\]. It is of particular interest to note that cells treated with 300 MCM hydrogen peroxide had a significant increase to nearly 60% of the cells with positive Beta Galactosidase staining. In cells treated with 400 MCM hydrogen peroxide, more than 80% of the cells were SA-beta-Gal positive. Similarly, in cells treated with 800 MCM hydrogen peroxide, about 80% of cells were positive for Beta Galactosidase, suggesting that 400 MCM is an optimum concentration of hydrogen peroxide to induce significant senescence in cultured ARPE19 cells.

Others have reported oxidative stress on human retinal pigment epithelial cells in culture \[[@R8], [@R9]\]. Arend *et al*. treated ARPE 19 cells with hydrogen peroxide for 2 hours (400 to 2000 MCM) and found no change in cell viability at 400 MCM \[[@R8]\]. This is contrary to our results in the present study showing a significant decrease in cell viability at 300, 400 and 800 MCM Fig. (**[1](#F1){ref-type="fig"}**). This may be due to a difference in experimental details (such as length of hydrogen peroxide incubation and passage number of our cell line, which may have increased senescence). In another study, Yu *et al*. treated primary cultures of human retinal pigment epithelial cells (at low passages P3-P5) with low hydrogen peroxide concentrations (50-150 MCM) \[[@R8]\]. In comparison to our study using a different cell line (ARPE19 with senescent-related changes), a direct comparison of results between our studies is not readily relevant.

CONCLUSION
==========

Our study shows that hydrogen peroxide treatment *in vitro* induces senescence in cultured ARPE 19 cells, likely from oxidative stress. Furthermore, hydrogen peroxide treatment also inhibited cell proliferation. Considering that our study focuses only on acute exposure to hydrogen peroxide, it clearly indicates that oxidative stress could possibly play a role in the pathogenesis of AMD \[[@R7], [@R8]\]. Additional studies such as inhibition of oxidative damage and supplementation with antioxidants will further validate this premise and shed more light on the nature of AMD development \[[@R10], [@R11]\].
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